These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31478563)
21. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells. Moody TW; Chiles J; Casibang M; Moody E; Chan D; Davis TP Peptides; 2001 Jan; 22(1):109-15. PubMed ID: 11179604 [TBL] [Abstract][Full Text] [Related]
22. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells. Kim JT; Li J; Song J; Lee EY; Weiss HL; Townsend CM; Evers BM Oncotarget; 2015 Sep; 6(29):26960-70. PubMed ID: 26298774 [TBL] [Abstract][Full Text] [Related]
23. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway. Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521 [TBL] [Abstract][Full Text] [Related]
24. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody. Wu Z; Fournel L; Stadler N; Liu J; Boullier A; Hoyeau N; Fléjou JF; Duchatelle V; Djebrani-Oussedik N; Agopiantz M; Ségal-Bendirdjian E; Gompel A; Alifano M; Melander O; Trédaniel J; Forgez P Cancer Lett; 2019 Mar; 444():147-161. PubMed ID: 30583074 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors. Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593 [TBL] [Abstract][Full Text] [Related]
26. Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth. Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Townsend CM Surg Oncol; 1996; 5(5-6):245-51. PubMed ID: 9129137 [TBL] [Abstract][Full Text] [Related]
27. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway. Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966 [TBL] [Abstract][Full Text] [Related]
28. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas. Rodríguez Y; Almeida TA; Valladares F; Báez D; Montes de Oca F; García C; Dorta I; Hernández M; Reyes R; Bello AR Biol Reprod; 2010 Oct; 83(4):641-7. PubMed ID: 20592307 [TBL] [Abstract][Full Text] [Related]
29. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3. Moody TW; Ramos-Alvarez I; Jensen RT Peptides; 2022 Oct; 156():170858. PubMed ID: 35932909 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells. Oury-Donat F; Thurneyssen O; Gonalons N; Forgez P; Gully D; Le Fur G; Soubrie P Br J Pharmacol; 1995 Sep; 116(2):1899-905. PubMed ID: 8528577 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma. Tornin J; Martinez-Cruzado L; Santos L; Rodriguez A; Núñez LE; Oro P; Hermosilla MA; Allonca E; Fernández-García MT; Astudillo A; Suarez C; Morís F; Rodriguez R Oncotarget; 2016 May; 7(21):30935-50. PubMed ID: 27105533 [TBL] [Abstract][Full Text] [Related]
32. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats. Karinch AM; Schmidt GL; Kauffman GL Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278 [TBL] [Abstract][Full Text] [Related]
33. Modifying Expression Modes of Human Neurotensin Receptor Type 1 Alters Sensing Capabilities for Agonists in Yeast Signaling Biosensor. Hashi H; Nakamura Y; Ishii J; Kondo A Biotechnol J; 2018 Apr; 13(4):e1700522. PubMed ID: 29131531 [TBL] [Abstract][Full Text] [Related]
34. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma. Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663 [TBL] [Abstract][Full Text] [Related]
35. Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception. Maeno H; Yamada K; Santo-Yamada Y; Aoki K; Sun YJ; Sato E; Fukushima T; Ogura H; Araki T; Kamichi S; Kimura I; Yamano M; Maeno-Hikichi Y; Watase K; Aoki S; Kiyama H; Wada E; Wada K Brain Res; 2004 Feb; 998(1):122-9. PubMed ID: 14725975 [TBL] [Abstract][Full Text] [Related]
36. Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells. Heakal Y; Kester M Mol Cancer Res; 2009 May; 7(5):724-34. PubMed ID: 19435815 [TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2. Hakozaki M; Hojo H; Sato M; Tajino T; Yamada H; Kikuchi S; Abe M Anticancer Res; 2006; 26(5A):3393-401. PubMed ID: 17094458 [TBL] [Abstract][Full Text] [Related]
38. Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents. De Vita A; Recine F; Mercatali L; Miserocchi G; Spadazzi C; Liverani C; Bongiovanni A; Pieri F; Casadei R; Riva N; Fausti V; Amadori D; Ibrahim T Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292724 [TBL] [Abstract][Full Text] [Related]
39. Neurotensin receptor-1 antagonist SR48692 modulation of high-fat diet induced reproductive impairment in male mice. Verma P; Pal H; Mohanty B Reprod Toxicol; 2024 Jan; 123():108498. PubMed ID: 37952698 [TBL] [Abstract][Full Text] [Related]
40. [Establishment and application of human CHO/NTR1 system]. Zhang G; Sun T; Liu HJ; Niu GJ; Xu F Yao Xue Xue Bao; 2014 Sep; 49(9):1273-8. PubMed ID: 25518326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]